Along with the drastic decline in the free circulating viral load, patients treated with RTIs were also observed to have a gradual increase in their CD4+ T-cell counts and, more importantly, the treatment also helped control Kaposi’s Sarcoma (KS) [47]. Here, CD4 is linked to Kaposi's sarcoma.